Pursuant to Regulation 30 read with Schedule III Part A(A) and in compliance of Regulation 47(1)(a) of SEBI (LODR) Regulations, 2015 regarding extract of Standalone and Consolidated Un-Audited Financial Results for the quarter/ half year ended on 30th September, 2021 which was approved by the Board in their 05/2021-2022 Board Meeting held on Wednesday, 10th November, 2021 at the Corporate Office of the Company situated at 201, Pushpratna Paradise 9/5 New Palasiya, Opposite UCO Bank Indore (MP) 452001. Medi-Caps has informed it enclosed the newspaper advertisement published on 12th November, 2021 in ‘Free Press Journal English edition and Choutha Sansar Hindi edition'.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| BASF India | 3703.10 |
| Tata Chemicals | 709.05 |
| SRF | 2493.65 |
| Pidilite Inds. | 1393.25 |
| Deepak Nitrite | 1538.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: